| 产品编号 | 图片 | CAS No. | 名称及描述 | 规格 | 价格 | 分子式 | 快速订购 |
|---|---|---|---|---|---|---|---|
| GC31734-1mg |
|
143584-75-2 |
S-methyl-KE-298 (M-2) - Glpbio |
0 | 需询价 | C13H16O3S | |
| GC31732-100mg |
|
79338-84-4 |
Tapinarof (WBI 1001) - Glpbio |
0 | 需询价 | C17H18O2 | |
| GC31732-50mg |
|
79338-84-4 |
Tapinarof (WBI 1001) - Glpbio |
0 | 需询价 | C17H18O2 | |
| GC31732-25mg |
|
79338-84-4 |
Tapinarof (WBI 1001) - Glpbio |
0 | 需询价 | C17H18O2 | |
| GC31732-10mg |
|
79338-84-4 |
Tapinarof (WBI 1001) - Glpbio |
0 | 需询价 | C17H18O2 | |
| GC31732-5mg |
|
79338-84-4 |
Tapinarof (WBI 1001) - Glpbio |
0 | 需询价 | C17H18O2 | |
| GC31732-10mM(1mLinDMSO) |
|
79338-84-4 |
Tapinarof (WBI 1001) - Glpbio |
0 | 需询价 | C17H18O2 | |
| GC31731-100mg |
|
2079896-25-4 |
GSK 4027 - Glpbio |
0 | 需询价 | C17H21BrN4O | |
| GC31731-50mg |
|
2079896-25-4 |
GSK 4027 - Glpbio |
0 | 需询价 | C17H21BrN4O | |
| GC31731-25mg |
|
2079896-25-4 |
GSK 4027 - Glpbio |
0 | 需询价 | C17H21BrN4O | |
| GC31731-10mg |
|
2079896-25-4 |
GSK 4027 - Glpbio |
0 | 需询价 | C17H21BrN4O | |
| GC31731-5mg |
|
2079896-25-4 |
GSK 4027 - Glpbio |
0 | 需询价 | C17H21BrN4O | |
| GC31731-10mM(1mLinDMSO) |
|
2079896-25-4 |
GSK 4027 - Glpbio |
0 | 需询价 | C17H21BrN4O | |
| GC31730-500mg |
|
56776-01-3 |
Tulobuterol hydrochloride - Glpbio |
0 | 需询价 | C12H19Cl2NO | |
| GC31730-100mg |
|
56776-01-3 |
Tulobuterol hydrochloride - Glpbio |
0 | 需询价 | C12H19Cl2NO | |
| GC31730-50mg |
|
56776-01-3 |
Tulobuterol hydrochloride - Glpbio |
0 | 需询价 | C12H19Cl2NO | |
| GC31730-10mM(1mLinDMSO) |
|
56776-01-3 |
Tulobuterol hydrochloride - Glpbio |
0 | 需询价 | C12H19Cl2NO | |
| GC31729-100mg |
|
2162962-69-6 |
CU-CPT-9b (TLR8-specific antagonist 1) - Glpbio |
0 | 需询价 | C16H13NO2 | |
| GC31729-50mg |
|
2162962-69-6 |
CU-CPT-9b (TLR8-specific antagonist 1) - Glpbio |
0 | 需询价 | C16H13NO2 | |
| GC31729-10mg |
|
2162962-69-6 |
CU-CPT-9b (TLR8-specific antagonist 1) - Glpbio |
0 | 需询价 | C16H13NO2 | |
小泰
|
010-60710855
|